Woodard & Company Asset Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66M Buy
3,052
+86
+3% +$87.9K 0.53% 40
2026
Q1
$2.73M Sell
2,966
-23
-0.8% -$23.3K 0.44% 43
2025
Q4
$3.21M Buy
2,989
+443
+17% +$424K 0.51% 36
2025
Q3
$1.94M Buy
2,546
+168
+7% +$125K 0.32% 47
2025
Q2
$1.85M Buy
2,378
+114
+5% +$88.6K 0.34% 46
2025
Q1
$1.87M Buy
2,264
+53
+2% +$44.1K 0.39% 37
2024
Q4
$1.71M Buy
2,211
+126
+6% +$104K 0.37% 39
2024
Q3
$1.85M Buy
2,085
+48
+2% +$43.2K 0.42% 37
2024
Q2
$1.84M Buy
2,037
+46
+2% +$36.8K 0.46% 32
2024
Q1
$1.55M Buy
1,991
+113
+6% +$80.4K 0.41% 37
2023
Q4
$1.09M Buy
+1,878
New +$1.1M 0.32% 43

Other funds holding LLY

Woodard & Company Asset Management Group's LLY Position: Q2 2026 in Review

Woodard & Company Asset Management Group increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $87.9K and bringing the position to 3,052 shares worth $3.66M. The position accounts for 0.53% of the portfolio, ranked #40.

Woodard & Company Asset Management Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,928 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Woodard & Company Asset Management Group held 3,052 shares of Eli Lilly worth $3.66M as of Q2 2026.
  • Woodard & Company Asset Management Group bought 86 Eli Lilly shares in Q2 2026, an estimated $87.9K.
  • Eli Lilly made up 0.53% of Woodard & Company Asset Management Group's portfolio in Q2 2026, its #40 holding.
  • Woodard & Company Asset Management Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,928 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Woodard & Company Asset Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.